← Open Payments lookup

LAWRENCE KENNARD: Open Payments

NPI 1558872531 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,048 in 56 payments from 24 companies in 2025. Trend: 2023 $73 · 2024 $0 · 2025 $1,048

Food & beverage: $1,048
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$164
Neurocrine BioSciences, Inc.5$94
Lundbeck LLC4$80
Astellas Pharma US Inc3$75
Corcept Therapeutics4$70
Bayer Healthcare Pharmaceuticals Inc.4$66
Sumitomo Pharma America, Inc.3$48
Otsuka America Pharmaceutical, Inc.3$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37

Products named: REXULTI, FARXIGA, INGREZZA, Veozah, Korlym, Kerendia, GEMTESA, XIFAXAN.

Industry payments across TN — which companies pay providers there.